Rated 4.98-stars across 4.8K+ reviews
Rated 4.98-stars across 3.9K+ reviews Rated 4.98-stars across 3.9K+ reviews Rated 4.98-stars across 3.9K+ reviews Rated 4.98-stars across 3.9K+ reviews Rated 4.98-stars across 3.9K+ reviews

Cancer and Genetics: What BRCA, Lynch and Risk Scores Really Tell You

Dr. Kaet (Lukkaet Laoprapaipan) profile image By
Dr. Kaet (Lukkaet Laoprapaipan)
|
Nov 22, 2026
|
50
Health
Genetics
disease
cancer and genetic risk
Summary
cancer and genetic risk

About 5–10% of cancers are clearly hereditary. Meet BRCA and Lynch genes, and why having both a gene mutation and a high PRS together raises risk even more — testable most completely with the WGS or MicroArray-plus-WES package.

Hi, I'm Dr. Kaet. A question I often hear in the genetics clinic is: "Several people in my family have had cancer — will I get it too, doctor?" It's an important question, because some cancers really are hereditary, and knowing in advance can meaningfully change a health plan. In this article I'll explain how cancer relates to genes, which key genes are worth knowing, and how far genetic information can help — without over-interpreting it.

Is cancer hereditary?

Partly, yes — but it's important to understand this correctly. Most cancers (around 90–95%) arise from mutations that accumulate in cells over a lifetime, driven by age, environment and behavior, and are not inherited from parents. Clearly hereditary cancer makes up about 5–10%, caused by mutations in single, high-impact genes passed down within families.

Signs that raise suspicion of hereditary cancer include several relatives affected, cancer at a young age, multiple cancers in one person, or a rare cancer type. If you have such a history, consult a doctor about genetic testing (read more in genetic cancer risk).

Cancer genes worth knowing: BRCA, Lynch and risk scores

The best-known genes are BRCA1 and BRCA2, which normally help repair DNA. When they are mutated, the risk of breast and ovarian cancer rises clearly. Another is Lynch syndrome, caused by faults in DNA mismatch-repair (MMR) genes, which raises the risk of colorectal and endometrial cancer.

Beyond single high-impact genes, a newer approach combines many genetic positions into a "polygenic risk score" to estimate the tendency toward common cancers such as breast and colorectal cancer in people without a single mutation (see the basics in What is a Polygenic Risk Score).

Family history and hereditary cancer genetic risk
Family history is an important clue — if several relatives have had cancer or at a young age, talk to a doctor about genetic testing.

When a mutation and a high score occur together, risk multiplies

A key point many people overlook is that hereditary cancer risk can come in "two layers" at once. The first layer is a single high-impact gene mutation, such as BRCA. The second is a polygenic risk score (PRS) built from many small positions. Research shows that when a person has both a gene mutation and a high PRS at the same time, the overall risk rises even higher, because the polygenic background modifies (raises) the penetrance of the single-gene variant.

That means assessing both layers together gives a more accurate picture than looking at either alone. The testing that covers both single genes and the combined score most completely at Geneus DNA is the WGS package, or MicroArray plus WES — WES/WGS help find high-impact single-gene mutations, while the 1-million-SNP microarray is the basis for calculating the PRS (compare the differences in how Microarray, WES and WGS differ).

What you can do: proactive screening

The real benefit of knowing your genetic risk is that it helps you plan screening earlier and more precisely — for example, high-risk individuals may start mammography or colonoscopy earlier than usual, or more frequently, as advised by their doctor. Catching cancer early usually leads to far better outcomes.

Genetic testing like Geneus DNA therefore has value as "supporting information" that helps you and your doctor see hidden risk and design a preventive care plan suited to you — alongside reducing controllable risk factors such as not smoking, managing weight, and regular check-ups.

Read it wisely: important cautions

This part is crucial. Carrying a risk mutation does not mean you will certainly develop cancer, and not finding one does not guarantee you are 100% safe — because a genetic risk score tells a "tendency," not a diagnosis. In addition, although most global reference data comes from European populations, Geneus DNA uses a multi-ethnic reference database that includes Thai and Asian populations, improving accuracy for Thai people. Even so, it should always be used as supporting information.

Most importantly, hereditary cancer results should be interpreted together with a doctor or genetic counselor, because there are medical, emotional and family dimensions to consider. Don't make major medical decisions from a test result alone without consulting a specialist.

1. Several people in my family have had cancer — will I definitely get it?

Not necessarily. Most cancers are not hereditary; only about 5–10% are clearly hereditary. If several relatives have had cancer or at a young age, consult a doctor about genetic testing.

2. What is the BRCA gene, and if I carry it will I definitely get cancer?

BRCA1 and BRCA2 help repair DNA; mutations clearly raise the risk of breast and ovarian cancer. But carrying a mutation does not mean you will definitely develop cancer — especially if your PRS is not high — though you should pursue closer screening and care with your doctor.

3. If I have both a gene mutation and a high PRS, is my risk higher than usual?

Yes. Research shows that having both a high-impact single-gene mutation and a high polygenic risk score (PRS) at the same time raises overall risk more than having either alone, because the polygenic background modifies the penetrance of the single-gene variant. Assessing both layers gives a more accurate picture — testable most completely at Geneus DNA with the WGS or MicroArray-plus-WES package.

4. When should I consider genetic testing for cancer?

Consider it especially if you have a family history of several affected relatives, cancer at a young age, or related cancer types. Always consult a doctor first to assess what to test and to interpret results appropriately together.

References

  1. National Cancer Institute (NCI). Genetic Testing for Inherited Cancer Susceptibility. cancer.gov
  2. MedlinePlus Genetics. BRCA1 gene. U.S. National Library of Medicine. medlineplus.gov
  3. MedlinePlus Genetics. Lynch syndrome. U.S. National Library of Medicine. medlineplus.gov
  4. Fahed AC, et al. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nature Communications. 2020. nature.com
Written by Dr. Kaet (Lukkaet Laoprapaipan)
chat line chat facebook